Re: Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size. Eur Urol 2009;55:472-81.
Chung
Shiu-Dong
SD
Chiu
Bin
B
Chuang
Yao-Chi
YC
Kuo
Hann-Chorng
HC
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D002114:Calcinosis / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000033:anatomy & histology*; D011469:Prostatic Diseases / Q000473:pathology; D011472:Prostatitis / Q000175:diagnosis / Q000503:physiopathology; D013449:Sulfonamides / Q000627:therapeutic use*; D000077409:Tamsulosin; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D014570:Urologic Diseases / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D013449:Sulfonamides; D000077409:Tamsulosin